Francesco Blasi1, Ying Wei, Mustafa Balkaya, Saara Tikka, Joseph B Mandeville, Christian Waeber, Cenk Ayata, Michael A Moskowitz. 1. From the Stroke and Neurovascular Research Laboratory, Department of Radiology (F.B., Y.W., M.B., C.A., M.A.M.), Stroke Service and Neuroscience Intensive Care Unit, Department of Neurology (C.A.), Department of Cell Biology (S.T.), and Department of Radiology, Martinos Center for Biomedical Imaging (J.B.M.), Massachusetts General Hospital, Harvard Medical School, Boston; and Department of Pharmacology, School of Pharmacy, University College Cork, Cork, Ireland (C.W.).
Abstract
BACKGROUND AND PURPOSE: Small subcortical white matter infarcts are a common stroke subtype often associated with cognitive deficits. The lack of relevant models confined to white matter has limited the investigation of its pathophysiology. Here, we examine tissue and functional outcome after an ischemic lesion within corpus callosum in wild-type (WT) mice and in mice null for a gene, NOTCH3, linked to white matter ischemic injury in patients. METHODS: WT and NOTCH3 knockout mice were subjected to stereotactic microinjections of the potent vasoconstrictor endothelin-1 at the level of periventricular white matter to induce a focal ischemic lesion. Infarct location was confirmed by MRI, and brains were examined for lesion size and histology; behavioral deficits were assessed ≤1 month in WT mice. RESULTS: Ischemic damage featured an early cerebral blood flow deficit, blood-brain barrier opening, and a lesion largely confined to white matter. At later stages, myelin and axonal degeneration and microglial/macrophage infiltration were found. WT mice displayed prolonged cognitive deficit when tested using a novel object recognition task. NOTCH3 mutants showed larger infarcts and greater cognitive deficit at 7 days post stroke. CONCLUSIONS: Taken together, these data show the usefulness of microinjections of endothelin-1 into periventricular white matter to study focal infarcts and cognitive deficit in WT mice. In short-term studies, stroke outcome was worse in NOTCH3 null mice, consistent with the notion that the lack of the NOTCH3 receptor affects white matter stroke susceptibility.
BACKGROUND AND PURPOSE:Small subcortical white matter infarcts are a common stroke subtype often associated with cognitive deficits. The lack of relevant models confined to white matter has limited the investigation of its pathophysiology. Here, we examine tissue and functional outcome after an ischemic lesion within corpus callosum in wild-type (WT) mice and in mice null for a gene, NOTCH3, linked to white matter ischemic injury in patients. METHODS: WT and NOTCH3 knockout mice were subjected to stereotactic microinjections of the potent vasoconstrictor endothelin-1 at the level of periventricular white matter to induce a focal ischemic lesion. Infarct location was confirmed by MRI, and brains were examined for lesion size and histology; behavioral deficits were assessed ≤1 month in WT mice. RESULTS:Ischemic damage featured an early cerebral blood flow deficit, blood-brain barrier opening, and a lesion largely confined to white matter. At later stages, myelin and axonal degeneration and microglial/macrophage infiltration were found. WT mice displayed prolonged cognitive deficit when tested using a novel object recognition task. NOTCH3 mutants showed larger infarcts and greater cognitive deficit at 7 days post stroke. CONCLUSIONS: Taken together, these data show the usefulness of microinjections of endothelin-1 into periventricular white matter to study focal infarcts and cognitive deficit in WT mice. In short-term studies, stroke outcome was worse in NOTCH3 null mice, consistent with the notion that the lack of the NOTCH3 receptor affects white matter stroke susceptibility.
Authors: Sanem A Aykan; Hongyu Xie; Yi Zheng; David Y Chung; Sreekanth Kura; James Han Lai; Taylan D Erdogan; Andreia Morais; Isra Tamim; Damla Yagmur; Hidehiro Ishikawa; Ken Arai; M Abbas Yaseen; David A Boas; Sava Sakadzic; Cenk Ayata Journal: Stroke Date: 2022-06-03 Impact factor: 10.170
Authors: Jared T Ahrendsen; Himmat S Grewal; Sean P Hickey; Cecilia M Culp; Elizabeth A Gould; Takeru Shimizu; Frank A Strnad; Richard J Traystman; Paco S Herson; Wendy B Macklin Journal: Glia Date: 2016-07-27 Impact factor: 7.452
Authors: Sanem A Aykan; Hongyu Xie; James Han Lai; Yi Zheng; David Y Chung; Sreekanth Kura; Maryam Anzabi; Kazutaka Sugimoto; Lauren M McAllister; M Abbas Yaseen; David A Boas; Michael J Whalen; Sava Sakadzic; Cenk Ayata Journal: Cereb Cortex Date: 2021-10-01 Impact factor: 4.861
Authors: Ekaterina Turlova; Raymond Wong; Baofeng Xu; Feiya Li; Lida Du; Steven Habbous; F David Horgen; Andrea Fleig; Zhong-Ping Feng; Hong-Shuo Sun Journal: Transl Stroke Res Date: 2020-05-19 Impact factor: 6.800
Authors: Fan Bu; Yashasvee Munshi; J Weldon Furr; Jia-Wei Min; Li Qi; Anthony Patrizz; Zachary R Spahr; Akihiko Urayama; Julia K Kofler; Louise D McCullough; Jun Li Journal: J Neurochem Date: 2020-10-06 Impact factor: 5.546